USI reviewed the pharmacy benefits of a 500 life packaging company, revealing unsustainable trends in specialty drug expenses. USI implemented cost containment programs that included prior authorization, step therapy and quantity limits. These changes were communicated to the company’s employees during open enrollment to ensure member’s clear understanding of the new programs. The reduced exposure to specialty drugs saved the company $25,000 in aggregate claims exposure and $10,000 in fixed premium. The step therapy program directed one member to a lower cost treatment, avoiding an expensive specialty alternative and resulting in over $700,000 annual pharmacy savings.